Gyn-Onc Flashcards
Preinvasive neoplastic disease of the vulva is divided into two categories
squamous
- vulvar intraepithelial neoplasia
nonsquamous intraepithelial neoplasias
- Paget disease
- melanoma in situ
Vulvar intraepithelial neoplasia
- definition
= cellular atypia contained within the epithelium
Characterized by:
- loss of epithelial cell maturation,
- cellular crowding,
- nuclear hyperchromatosis,
- abnormal mitosis
How is the lesion of VIN determined?
Mild - severe dysplasia based on depth of epithelial involvement
VIN 1 = koilocytic atypia
VIN 2 &3 = Usual VIN vs Differentiated VIN
How many % of pts with VIN will have coexisting invasive carcionma (penetrated BM)
20%
Risk factors for VIN
HPV 16, 18
- 80-90% VIN will have DNA fragments from HPV
- 60% of women w/ VIN will have cervical neoplasia too
Cigarette smoking
Immunodeficiency
Immunosuppression
Most VIN are in premenopausal women (75%)
- median age = 40 yo
- incidence decreases as age increases
VIN has 2 distinct forms - what are they?
Younger premenopausal women
- more likely to have more aggressive multifocal lesions that rapidly become invasive and are associated with HPV 75% to 100% of the time.
Older postmenopausal women
- more likely to involve focal lesions that are slow to become invasive
- not typically associated with HPV
Sx of VIN
- vulvar pruritus or vulvar irritation
- palpable abnormality,
- perineal or perianal burning,
- dysuria
Often, these women would have been examined several times and diagnosed with candidiasis, but experience no relief of symptoms with antifungal treatments or topical steroids.
Any time a pruritic area of the vulva does not respond to topical antifungal creams - what should be done?
further evaluation with vulvar biopsy should be undertaken
Tx VIN
VIN + no evidence of invasion
- wide local excision
- disease free margin of at least 5-10 mm
VIN + multifocal disease
- simple vulvectomy or skinning vulvectomy
- use split thickness grafts to replace excised lesions
- can use laser vaporization to eradicate multifocal lesions
- younger –> 5-FU topical and imiquod but only 40-50% effective
Follow up for VIN
Recurrence 18-55%
- more common w/ multifocal lesions, mod-severe dysplasia, + margins
Colposcopy of entire genital tract q6 months for 2 years
- after 2 years, do this yearly
Paget disease of the vulva - age of presentation
50-80 yo
Is extramammary paget disease of the invasive? Does it recurr?
NOT invasive usually
Tends to recurr locally
Only 20% of pts w/ pagets NOT of breast will have underlying adenocarcionma
- mets common with this
Dx Paget disease of vulva
Lesions consistent w/ chronic inflammatory changes
Usually there’s a long standing pruritus that accompanies velvety red lesions of skin —> eczematous and scar into white plaques
Usually > 60 yo
Tx paget disease of vulva
Wide local excision if not invasion
BE CAREFUL! It is fatal if it spreads to lymph nodes
1 vulvar cancer
Squamous cell carcionma
Most are on labia majora
Spread of vulvar cancer is via
lymphatics –> superficial inguinal lymph nodes
Vulvar carcinoma accounts for what % of GYN cancers?
5%
Staging of vulvar carcionma
Surgically staged
- radical local excision + inguino-femoral LN dissection
- if superficial (< 1 mm) and unilateral disease, can forego unilateral LN dissection
Tx vulvar carcionma
For all
- wide radical local excision
- LN dissection
+
Stage 1
- ipsilateral lymphadenectomy
Stage 2
- modified radial vulvectomy
- resection LN
Stage 3 + 4
- radical vulvectomy
Tx Melanoma of the vulva
.
occurs predominantly in postmenopausal Caucasians
It can be treated similarly to SCC, except that lymphadenectomy is rarely performed
Depth of invasion is the key prognostic factor.
Once the melanoma has metastasized, the mortality rate is near 100%
The 5-year survival rate for all patients after surgical treatment of invasive SCC of vulva is approximately
75%
The most important prognostic factor is the number of positive inguinal lymph nodes
Vaginal intraepithelial neoplasia (VAIN) is a
premalignant lesion similar to that of the vulva and cervix.
However, VAIN is much less common than either VIN or CIN.
Dx VAIN
Usually asymptomatic
- if sx: vaginal d/c or postcoital spotting, abnl pap smear
- suspicion of vaginal neoplasia should be raised in patients with persistently abnormal Pap smears but no cervical neoplasia detected on colposcopy or cervical biopsy.
- Pts s/p hysterectomy for a history of high grade CIN should continue to have annual Pap smears to screen for VAIN until three consecutive negative Pap tests have been obtained
- VAIN can be diagnosed with a thorough colposcopy of the cervix (if present) and upper vagina using both acetic acid and Lugol’s solution
Tx VAIN
- local excision or laser ablation
Intravaginal 5-FU useful for tx pts w/ multifocal lesions and immunosuppression
Most types of vaginal cancer
Squamous cell carcinoma
- may appear ulcerated, nodular, or exophytic
- usually involves the posterior wall and upper one-third
of the vagina.
Spread may occur via lymphatic drainage to the inguinal nodes and deep pelvic nodes or via direct extension to the bladder or rectum.
What vaginal cancer was found to be associated w/ in utero exposure of diethylstilbestrol?
Clear cell adenocarcionma
The cause of SCC of the vagina is
unknown
Similar to vulvar and cervical cancers, vaginal cancers can be associated with HPV infection.
- However, because the vaginal mucosa is not undergoing constant metaplasia like cervical epithelium, the vagina is much less susceptible to the oncogenic effects of the virus
Does vaginal cancer have better 5 years survival than vulvar cancer?
NO!
40-55%
Tx vaginal carcinoma
Small stage I malignancies of the upper vagina can be treated with surgical excision
all other lesions are treated with internal and external radiation therapy
When does CIN more commonly occur?
menarche and after pregnancy
- During menarche, the production of estrogen stimulates metaplasia in the transformation zone (TZ) of the cervix.
- These metaplastic cells are more susceptible to oncogenic factors
Risk factors for cervical dysplasia include
- characteristics that predispose to multiple and early
exposure to HPV (early intercourse, multiple sexual partners, early childbearing, “high-risk” partners, low socioeconomic status, and sexually transmit-ted infections). - cigarette smoking
- Immunodeficiency / Immunosuppression
Screening guidelines for cervical cancer
All women should begin cervical cancer screening at age 21 regardless of risk factors, including age of onset of sexual activity.
Onset of sexual intercourse
- if HIV +, SLE, organ transplants
- q6 months x2, then annually
Age 21-29
- pap test q3 years
> 30 yo
- screen with both a Pap test and an HPV test
- –if both (-) –> q5 yr screening Pap + HPV test
- if HPV testing NOT available, screen w/ pap smear q3 yr
> 65 yo
- stop screening if >=3 nl Pap tests in a row, have not had CIN 2/3 or higher in past 20 years
- if had CIN 2/3, screen for 20 years after; stop then or at 65, whichever is later
Total hysterectomy for benign indications + no hx CIN 2/3 or higher
- can stop pap tests at time of hysterectomy
Total hysterectomy + hx of CIN 2 or 3
- stop Pap smear after 20 yr or age 65, whichever later
If supracervical hysterectomy, need to continue routine Pap test screening appropriate for age
If pt is Negative for intraepithelial lesion and malignancy pap, High-risk HPV positive
What do you do?
Repeat both pap and HPV in 1 year
OR
screen for HPV 16 and 18.
If either is positive then immediate colposcopy
ASC-US (Atypical squamous cells of undetermined significance)
+
High-risk HPV negative
What do you do?
Continue routine pap smear screening
You always get an HPV status if the pap is abnormal/ASCUS
When do you do colposcopy and cervical biopsies?
You do a colpo for all ASCUS that are also HPV + and anything higher
ASC-US + High-risk HPV positive
ASC-H (Atypical squamous cells cannot exclude high-grade squamous intraepithelial lesion)
LSIL (Low-grade squamous intraepithelial lesion)
HSIL (High-grade squamous intraepithelial lesion)
No need to do HPV for anything higher than ASCUS (ASCH, LSIL, HSIL)
When do you do colposcopy + cervical bx + endometrial bx?
atypical glandular cells
Pap smear reveals SCC - what do you do?
Colposcopy , HPV screen, and cervical biopsies, potential cold-knife conization (CKC)
When do you not test for high risk HPV?
no high-risk HPV testing is recommended for ASC-H, LSIL, and HSIL, because nearly all of these lesions will be positive for high-risk HPV types
Changes that can be seen on colposcope stained with acetic acid on cervix
Acetowhite epithelium
Mosaicism
Punctation
Atypical vessels
Bx all these lesions and send to path
% regress spontaneously in CIN I - III
CIN 1 = 60
CIN 2 = 40
CIN 3 = 30
Management of
CIN
CIN II
CIN III
CIN I
- repeat Pap q6 months for 1 year OR
- High risk HPV screen in 1 yr…..if persistent x 2 year, offter LEEP procedure (loop electrosurgical excision procedure)
- if all paps WNL, can return to pap test appropriate for age
CIN II
- LEEP OR
- repeat pap + colpo q6months for 2 years for young women
CIN III
- LEEP
Surgical excision options for cervical dysplasia based on characteristics of lesion or patient
- when use:
- LEEP?
- laser conization?
- Cold knife conization?
LEEP
- if confined to ectocervix
Laser conization
- large lesion
- upper vagina involved
LEEP (2 stage) or CKC
- endocervix involved
excisional procedure, such as cold knife biopsy or LEEP, is not warranted without a tissue diagnosis of dysplasia
Types of cervical cancer
Squamous cell (80%)
Adenocarcionma (20%) - usually DES exposure if clear cell
How much does routine pap smear + HPV typing decrease risk of cervical cancer?
90%
High Risk HPV serotypes
16
18
31
45
Sx of cervical cancer
1 sx = postcoital bleeding
Early disease = asymptomatic
Mass on bimanual
Abnl vaginal bleeding
Dx cervical cancer
Tissue bx s/p abnormal pap or lesion found
Cervical cancer staging
ONLY GYN cancer that is CLINICALLY staged
- cannot use MRI or CT to stage
Stage w/ :
- exam under anesthesia
- CXR
- cystoscopy
- proctopscopy
- IVP
- barium enema
Stage I
- confined to cervix
Stage II
- beyond cervix but not to pelvic side walls or lower 1/3 of vagina
Stage III
- extend to pelvic sidewalls or lower 1/3 vagina
Stage IV
- extension beyond pelvis, invasion into local structures (eg bladder, rectum) or distant mets
Tx cervical cancer
Stage 0 + 1
- simple hysterectomy
- cold knife cone if want to maintain fertility
- 5yr survival = 85-90%
Stage II
- radial hysterectomy or radiation
- 5yr survival = 60-75%
Stage IIb - IV
- Chemoradiation (cisplatin + radiation)
- 5yr survival as low as 15%
Tx recurrence cervical cancer
If only surgery 1st round –> radiation to tx
If already radiated –> surgery + pelvic exenteration (remove all pelvic organs)
Classification of Ovarian neoplasms
By cell type
Epithelial
- Serous (#1) cystadenoma / cystadenocarcionma
- Mucinous (#2) cystadenoma / cystadenocarcionma
- Endometriod (M) - assoc w/ endometriosis
- Brenner
Germ cell
- Teratoma
- Dysgerminoma (M)
- Embryonal carcionma
- –Endodermal sinus (yolk sac) - extraembryonic tissues
- –Choriocarcionma (M) - trophoblastic (placental) tissues
- –Immature teratoma - embryonic (fetal) tissues
Stromal cell
- Granulosa theca (M)
- Sertoli-Leydig (M)
- Lipid cell fibroma
Malignant epithelial serous tumors (serous cystadenocarcionma)
1 malignant epithelial cell tumors
Can arise from benign serous cysadenoma
Psammoma bodies
Malignant mucinous epithelial tumor (mucinous cyadenocarcionma)
2 malignant epithelial cell tumor
Lower rate of bilaterality
Associated w/ pseudomyxomatous peritonei = widespread peritoneal extension with thick, mucinous ascites
Meigs syndrome
Ascites
R pleural effusion
Benign ovarian fibroma (stromal neoplasm)
Genes increasing risk of ovarian cancer
Risk factors of ovarian cancer
BRCA 1
HNPCC
Risk factors:
- long periods of uninterrupted ovulation (early menarche, infertility, nulliparity, delayed childbearing, lateonset
menopause) - older age
- use of talcum powder on the perineum
- obesity (BMI > 30).
1 ovarian cancers in women < 20 yo
Germ cell tumors
Blacks and asians more common than caucasians
When is CA-125 useful in ovarian cancer?
Postmenopausal women with pelvic mass can predict higher likelihood of malignant neoplasm w/ CA 125
- but nl CA 125 doesn’t r/o cancer
Not as useful in premenopausal becausse many benign conditions (PID, uterine leiomyomata, etc) can cause increased CA 125
Tumor markers for germ cell tumors
hCG - choriocarcionmas
AFP - endodermal sinus
LDH - dysgerminomas
Dysgerminomas
Germ cell malignant tumor of ovary
Unilateral #1 germ cell tumor in pts w/ gonadal dysgenesis
Radio + chemosensitive
Spread via lymphatics
What is esp important in ovarian tumors such as granulosa tumor?
Endometrial sampling
These tumors can secrete estrogen –> endometrial hyperplasia –> carcionma
What do the stromal cell malignant ovarian cancers secrete?
Graunlosa –> estrogen
Sertoli Leydig –> testosterone
Krukenberg tumor
Ovarian tumor that is metastatic from other sites like the GI and breast
Usually signet ring cell type
Bilateral